亚急性神经毒性作为Ceftazidime的副作用:一个病例报告
Filipe Oliveira Pinheiro1, Delfim Duarte2, Pedro Rodrigues3
1Rheumatology Department, Centro Hospitalar Universitário de São João.
The Kurume medical journal
|January 17, 2024
概括
塞法胺是一种抗生素,可以引起罕见的神经毒性,特别是在患有脏疾病的老年患者中. 立即停止使用药物导致症状恢复.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 神经毒性是塞法洛斯波林抗生素的新出现的并发症.
- 很少有人报告CEFTAZIDIME诱导的神经毒性,特别是在亚急性呈现时.
- 患有功能障碍的老年患者的风险更高.
研究的目的:
- 在慢性病的老年患者中报告一种与塞夫塔齐相关的亚急性神经毒性的罕见病例.
- 突出认识到在风险人群中Ceftazidime神经毒性的重要性.
主要方法:
- 一个77岁的女性患者的病例报告,患有4期慢性病.
- 启动对管相关细菌血症的万科米辛和塞夫塔齐迪姆的治疗.
- 观察临床表现,神经毒性症状和药物戒断反应.
主要成果:
- 经过13天的塞夫塔齐迪姆治疗,患者出现了混乱,迷失方向和肌.
- 随着神经毒性症状的同时,人们注意到功能恶化.
- 停止治疗塞夫塔齐迪姆导致8天内症状完全缓解.
结论:
- 塞法胺神经毒性是一种罕见但潜在的未被确诊的不良反应.
- 风险因素包括晚年,先前存在的神经问题和严重病 (CKD/AKI).
- 早期识别和药物戒断对于患者的康复至关重要.
相关概念视频
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


